ReviewFrontiers in pharmacology2025

Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis.

Yusuf YilmazPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.